PMV Pharmaceuticals, Inc.'s latest layoff filing, on January 18, 2024, states a cut of about 30% of its workforce. As of November 14, 2026, it has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, January 18, 2024).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of PMV Pharmaceuticals, Inc.
Free to see. No signup.
People from PMV Pharmaceuticals, Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the PMV Pharmaceuticals, Inc. layoff? Add yourself to the open-to-work list, free
Your entry
PMV Pharmaceuticals, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did PMV Pharmaceuticals have layoffs in 2024? What its filings say
PMV Pharmaceuticals, Inc. (CIK 1699382) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2024-01-18
Share of workforce
On January 18, 2024, PMV Pharmaceuticals, Inc. (the " Company ") announced a restructuring plan involving the reduction of its workforce by approximately 30% of the Company's employees.
Expected charges
As a result of the reduction in force, the Company expects to incur aggregate non-recurring charges of approximately $1.4 million, consisting primarily of employee severance and benefit costs associated with the restructuring.
Timing
The Company expects the reduction in workforce to be substantially completed by June 30, 2024, and fully completed by the end of the third quarter of 2024.
Also on the record for PMV Pharmaceuticals, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 5, 2026 | Leadership change: Matthew Eckler appointed, Director | — | Leadership changes | Source |
| September 15, 2026 | Stake report, Schedule 13G, by Srinivas Akkaraju | 9.9% of the class | 5%+ stakes | Source |
| July 28, 2026 | Stake report, Schedule 13G/A, by Sio Capital Management, LLC | 4.94% of the class | 5%+ stakes | Source |
| July 10, 2026 | Stake report, Schedule 13G/A, by ArrowMark Colorado Holdings, LLC | 3.67% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Euclidean Capital LLC | 4.9% of the class | 5%+ stakes | Source |
| May 4, 2026 | Stake report, Schedule 13G/A, by Sio Capital Management, LLC | 5.77% of the class | 5%+ stakes | Source |
| March 4, 2026 | Stake report, Schedule 13D/A, by ORBIMED ADVISORS LLC | — | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by ArrowMark Colorado Holdings, LLC | 5.81% of the class | 5%+ stakes | Source |
| February 9, 2026 | Stake report, Schedule 13G/A, by BML Investment Partners, L.P. | 9.9% of the class | 5%+ stakes | Source |
| November 12, 2025 | Stake report, Schedule 13G/A, by Sio Capital Management, LLC | 4.98% of the class | 5%+ stakes | Source |
| October 27, 2025 | Stake report, Schedule 13D/A, by ORBIMED ADVISORS LLC | 9.4% of the class | 5%+ stakes | Source |
| September 23, 2025 | Stake report, Schedule 13G, by TANG CAPITAL MANAGEMENT, LLC | 8.9% of the class | 5%+ stakes | Source |
Keep reading
More on PMV Pharmaceuticals, Inc. and the records around it.
PMV Pharmaceuticals, Inc. elsewhere on the record
- Leadership changes Oct 2026
- 5%+ stake filings Sep 2026
- Who owns it
Companies that share a holder
- PFM Health Sciences, LP also filed stake reports on 2 other companies: Outset Medical, Inc. (Feb 2026), Werewolf Therapeutics, Inc. (Aug 2025)
- ArrowMark Colorado Holdings, LLC also filed stake reports on 9 other companies: Sprout Social, Inc. (Apr 2026), CIMPRESS plc (Feb 2026), ZIFF DAVIS, INC. (Feb 2026)
- Sio Capital Management, LLC also filed stake reports on 9 other companies: Enveric Biosciences, Inc. (Nov 2026), Adagio Medical Holdings, Inc. (Jul 2026), Anteris Technologies Global Corp. (May 2026)
Watch PMV Pharmaceuticals, Inc.
Get an email when PMV Pharmaceuticals, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with PMV Pharmaceuticals, Inc.?
Want the whole picture on PMV Pharmaceuticals, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on PMV Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on PMV Pharmaceuticals, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 14 records.
Tools for this story
Each opens in a new tab, filled in for PMV Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns PMV Pharmaceuticals, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/pmv-pharmaceuticals